Neogen (NEOG) Non-Current Debt (2011 - 2026)
Neogen (NEOG) posted quarterly Non-Current Debt of $793.7 million for Q2 2026, down 9.27% year-over-year from $874.8 million in Q2 2025, and little changed quarter-over-quarter from $793.3 million in Q1 2026.
Neogen (NEOG) Non-Current Debt (2011 - 2026) Analysis & Trends
Neogen's Non-Current Debt history runs 12 years deep, the most recent figure standing at $793.7 million for Q2 2026.
- In Q2 2026, Non-Current Debt fell 9.27% year-over-year to $793.7 million; the TTM figure through May 2026 stood at $793.7 million (down 9.27% YoY), while the FY2026 annual figure was $793.7 million, down 9.27% from the prior year.
- Non-Current Debt for Q2 2026 stood at $793.7 million, roughly flat from $793.3 million in the prior quarter.
- The five-year high for Non-Current Debt was $924.0 million in Q4 2022, with the low at $792.5 million in Q3 2025.
- The 5-year median for Non-Current Debt is $886.2 million (2023), against an average of $864.0 million.
- The sharpest annual moves came in 2024 and 2026: Non-Current Debt gained 0.33% in 2024, then fell 10.93% in 2026.
- Neogen's Non-Current Debt stood at $924.0 million in 2022, then dropped by 4.01% to $886.9 million in 2023, then increased by 0.33% to $889.9 million in 2024, then decreased by 10.89% to $792.9 million in 2025, then climbed by 0.1% to $793.7 million in 2026.
- Business Quant data shows NEOG's Non-Current Debt at $793.7 million in Q2 2026, $793.3 million in Q1 2026, and $792.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Neogen | 2.56 Bn | 2.37 Bn | 107.80 Mn | 793.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 793.70 Mn |
| Feb 28, 2026 | 793.30 Mn |
| Nov 30, 2025 | 792.93 Mn |
| Aug 31, 2025 | 792.53 Mn |
| May 31, 2025 | 874.80 Mn |
| Feb 28, 2025 | 890.61 Mn |
| Nov 30, 2024 | 889.87 Mn |
| Aug 31, 2024 | 889.13 Mn |
| May 31, 2024 | 888.39 Mn |
| Feb 29, 2024 | 887.65 Mn |
| Nov 30, 2023 | 886.92 Mn |
| Aug 31, 2023 | 886.18 Mn |
| May 31, 2023 | 885.44 Mn |
| Feb 28, 2023 | 884.70 Mn |
| Nov 30, 2022 | 923.96 Mn |
| Feb 28, 2017 | 3.23 Mn |
| Nov 30, 2016 | 2.25 Mn |
| Aug 31, 2016 | 2.22 Mn |
| May 31, 2016 | 2.42 Mn |
| Feb 29, 2016 | 2.11 Mn |